Clinical Trial Update: Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir [Phase 1]

View source ↗

Summary

Phase 1 study in healthy adults evaluating the pharmacokinetics, safety, and tolerability of ABT-450 boosted with ritonavir for potential hepatitis C treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-450 (atazanavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Abbott | Conditions: HCV Infection | Phase 1 | Status: COMPLETED